ICare Stem Cell Research Center, Taipei 100, Taiwan.
Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Int J Mol Sci. 2021 Nov 23;22(23):12623. doi: 10.3390/ijms222312623.
As a source of growth factors for expediting wound healing and tissue regeneration, plasma-rich plasma (PRP) has been extensively applied in diverse fields including orthopaedics, ophthalmology, oral and maxillofacial surgery, dentistry, and gynaecology. However, the function of PRP in metabolic regulations remains enigmatic. A standardized method was devised herein to enrich growth factors and to lyophilize it as enhanced PRP (ePRP) powder, which could become ubiquitously available without mechanical centrifugation in clinical practice. To identify metabolic reprogramming in human dermal fibroblasts under ePRP treatment, putative metabolic targets were identified by transcriptome profiling and validated for their metabolic effects and mechanism. ePRP does not only promote wound healing but re-aligns energy metabolism by shifting to glycolysis through stimulation of glycolytic enzyme activity in fibroblasts. On the contrary, oxygen consumption rates and several mitochondrial respiration activities were attenuated in ePRP-treated fibroblasts. Furthermore, ePRP treatment drives the mitochondrial resetting by hindering the mitochondrial biogenesis-related genes and results in a dampened mitochondrial mass. Antioxidant production was further increased by ePRP treatment to prevent reactive oxygen species formation. Besides, ePRP also halts the senescence progression of fibroblasts by activating expression. Importantly, the glycolytic inhibitor 2-DG can completely reverse the ePRP-enhanced wound healing capacity, whereas the mitochondrial inhibitor oligomycin cannot. This is the first study to utilize PRP for comprehensively investigating its effects on the metabolic reprogramming of fibroblasts. These findings indicate that PRP's primary metabolic regulation is to promote metabolic reprogramming toward glycolytic energy metabolism in fibroblasts, preserving redox equilibrium and allowing anabolic pathways necessary for the healing and anti-ageing process.
富血小板血浆(PRP)作为促进伤口愈合和组织再生的生长因子来源,已广泛应用于骨科、眼科、口腔颌面外科、牙科和妇科等多个领域。然而,PRP 在代谢调节中的功能仍然是一个谜。本文设计了一种标准化方法来富集生长因子,并将其冻干成增强型 PRP(ePRP)粉末,以便在临床实践中无需机械离心即可广泛获得。为了确定 ePRP 处理下人真皮成纤维细胞中的代谢重编程,通过转录组谱分析鉴定了潜在的代谢靶标,并验证了它们的代谢作用和机制。ePRP 不仅促进伤口愈合,而且通过刺激成纤维细胞中糖酵解酶的活性,通过糖酵解重新调整能量代谢。相反,ePRP 处理的成纤维细胞中的耗氧率和几种线粒体呼吸活性减弱。此外,ePRP 通过抑制与线粒体生物发生相关的基因,阻碍线粒体的重置,导致线粒体质量减弱。ePRP 处理还通过增加抗氧化剂的产生来防止活性氧的形成。此外,ePRP 通过激活 表达来阻止成纤维细胞的衰老进程。重要的是,糖酵解抑制剂 2-DG 可以完全逆转 ePRP 增强的伤口愈合能力,而线粒体抑制剂寡霉素则不能。这是首次利用 PRP 全面研究其对成纤维细胞代谢重编程的影响的研究。这些发现表明,PRP 的主要代谢调节作用是促进成纤维细胞向糖酵解能量代谢的代谢重编程,维持氧化还原平衡,并允许愈合和抗衰老过程所需的合成代谢途径。